The purpose of this research study is to find out if denosumab (Prolia®), an injection given
in the arm under the skin every 6 months, works to treat bone loss and prevent it from
worsening in older men and women (ages 65 and older) who have osteoporosis and reside in
long-term care (LTC) facilities.
Phase:
Phase 4
Details
Lead Sponsor:
Susan L. Greenspan University of Pittsburgh
Collaborators:
National Institute on Aging (NIA) National Institutes of Health (NIH)
Treatments:
Calcium Calcium, Dietary Denosumab Ergocalciferols Vitamin D Vitamins Zoledronic Acid